1. Home
  2. ARWR vs VVX Comparison

ARWR vs VVX Comparison

Compare ARWR & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • VVX
  • Stock Information
  • Founded
  • ARWR 2003
  • VVX 2014
  • Country
  • ARWR United States
  • VVX United States
  • Employees
  • ARWR N/A
  • VVX N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • VVX Diversified Commercial Services
  • Sector
  • ARWR Health Care
  • VVX Consumer Discretionary
  • Exchange
  • ARWR Nasdaq
  • VVX Nasdaq
  • Market Cap
  • ARWR 1.8B
  • VVX 1.6B
  • IPO Year
  • ARWR 1993
  • VVX 2014
  • Fundamental
  • Price
  • ARWR $16.07
  • VVX $45.21
  • Analyst Decision
  • ARWR Buy
  • VVX Buy
  • Analyst Count
  • ARWR 10
  • VVX 8
  • Target Price
  • ARWR $42.13
  • VVX $65.25
  • AVG Volume (30 Days)
  • ARWR 1.9M
  • VVX 288.2K
  • Earning Date
  • ARWR 05-12-2025
  • VVX 05-05-2025
  • Dividend Yield
  • ARWR N/A
  • VVX N/A
  • EPS Growth
  • ARWR N/A
  • VVX N/A
  • EPS
  • ARWR N/A
  • VVX 1.29
  • Revenue
  • ARWR $545,209,000.00
  • VVX $4,327,514,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • VVX $4.23
  • Revenue Next Year
  • ARWR $66.56
  • VVX $4.71
  • P/E Ratio
  • ARWR N/A
  • VVX $35.15
  • Revenue Growth
  • ARWR 1436.97
  • VVX 7.38
  • 52 Week Low
  • ARWR $9.57
  • VVX $41.08
  • 52 Week High
  • ARWR $30.41
  • VVX $69.75
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 59.58
  • VVX 37.86
  • Support Level
  • ARWR $14.92
  • VVX $45.25
  • Resistance Level
  • ARWR $17.19
  • VVX $48.00
  • Average True Range (ATR)
  • ARWR 0.95
  • VVX 1.60
  • MACD
  • ARWR 0.11
  • VVX -0.51
  • Stochastic Oscillator
  • ARWR 70.29
  • VVX 13.20

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

Share on Social Networks: